Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-28
1996-05-07
Datlon, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 39, C07D22122, A61K 31435
Patent
active
055146848
ABSTRACT:
Novel aconitine compounds of the formula ##STR1## wherein the symbols are as defined in the description, as well as analgesic/anti-inflammatory agent containing them or salts thereof as active ingredient.
REFERENCES:
patent: 5290784 (1994-03-01), Qu et al.
Murayama et al, Chem. Abstract 112:21188p (1990) for JP 01-143859 (Jun. 6, 1989).
The Merck Index, 11th ed (1989), Merck and Co. Inc., p. 18.
Takayama et al, Chem. Pharm. Bull, 30(1), (1982), pp. 386-389.
Chemical and Pharmaceutical Bulletin, vol. 39, No. 2, Feb. 1991, Tokyo JP, pp. 379-383; Mori et al: "Studies on the Constitutents of Aconitum Species. XII. Syntheses of Jesaconitine Derivatives and Their Analgesic and Toxic Activities".
Chemical Abstracts, vol. 116, No. 11, 16 Mar. 1992, Columbus, OH; Abstract No. 106574, p. 808; & JP-A-03 223 255 (Sanwa Seeiyaku Co. Ltd.) 2 Oct. 1991.
Grant & Hackh's Chemical Dictionary, 5th ed (1987), Roger Grant et al., p. 22.
Mori Takao
Murayama Mitsuo
Datlon Philip I.
Sanwa Shoyaku Kabushiki Kaisha
LandOfFree
Aconitine compounds and analgesic/anti-inflammatory agent contai does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aconitine compounds and analgesic/anti-inflammatory agent contai, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aconitine compounds and analgesic/anti-inflammatory agent contai will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227460